Implantica to present Q1 2025 results on May 9
Implantica AG (publ) invites investors to a presentation of its first quarter 2025 financial report on May 9 at 3:00 PM CEST. The interim report for the quarter will be published at 8:00 AM CEST on the same morning.
Implantica AG (publ) will host an investor presentation for its first quarter 2025 financial results on Thursday, May 9, at 3:00 PM CEST. The company's interim report for the quarter is scheduled for release at 8:00 AM CEST on the same day.
The presentation, conducted in English, will be available via a webcast and a conference call. Participants can access the webcast through a provided link on Implantica's website. Registration is required for the conference call, after which participants will receive dial-in details.
Speakers at the event will include CEO Peter Forsell, CFO Andreas Öhrnberg, and Chief Corporate Affairs Officer Nicole Pehrsson. Implantica is a medical technology company focused on implantable devices, with its primary product, RefluxStop™, being CE-marked for the treatment of acid reflux. The company is listed on the Nasdaq First North Premier Growth Market.
Additional details and contact information for investor inquiries are available from the company. Implantica is also developing advanced e-health solutions and wireless energy platforms for implantable devices.